Monitor the shareholder vote outcome at the 2026 annual meeting. A surprise approval of the independent chair proposal could signal governance pressure, but historical rejection rates suggest low probability. No immediate trading catalyst.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 8 $17.81entry
- T+1 · 6mo ago −0.45%α −0.68% · $17.73
- T+5 · 6mo ago −1.40%α −2.87% · $17.56
- T+20 · 5mo ago −3.87%α −3.90% · $17.12
- T+60 · 3mo ago −4.83%α −9.67% · $16.95
Price Chart
How similar events traded
Executive Summary
JPMorgan management filed additional definitive proxy soliciting materials to rebut ISS's recommendation in favor of a shareholder proposal for an independent chair. Management argues ISS ignored the board's rationale, the company's strong performance under the combined CEO/Chair structure, and the board's commitment to separate the roles upon the next CEO transition. The filing is a routine governance debate with no material financial impact.
Key Financial Metrics
Key Facts
- JPMorgan management is responding to ISS's recommendation supporting Proposal 5 (independent chair shareholder proposal).
- Management argues the combined CEO/Chair structure has driven outperformance vs. peers on ROTCE and TSR over 1-, 3-, and 5-year periods.
- The board amended Corporate Governance Principles in 2022 to separate Chair and CEO roles upon the next CEO transition.
- Lead Independent Director Stephen B. Burke has received >90% shareholder support in each election during his tenure.
- Management contends the proposal's prescriptive requirements could violate Delaware law.
- Shareholders have consistently rejected similar independent chair proposals in prior years.
Financial Impact
No financial figures disclosed; governance debate only.
Risk Factors
- Shareholder proposal for independent chair could pass despite management opposition, signaling governance discontent.
- ISS may revise its recommendation after management's rebuttal, potentially shifting vote outcomes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001628280-26-032233 |
| Document: 0001628280-26-032233-index-headers.html | 0001628280-26-032233 |
| Document: 0001628280-26-032233-index.html | 0001628280-26-032233 |
| Document: 0001628280-26-032233.txt | 0001628280-26-032233 |
Track record
90 reports on JPM
11 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +20.20% at T+60 after the May 29, 2026 report. 12 of 13 went positive at some point.
Filters
- Nov 12, 20264d ago 13F-HR Neutral 2/10 Entry $342.82 Now $338.21 −1.34% settles Dec 11
- Nov 11, 20266d ago Court Ruling Neutral 1/10 Entry $342.82 Now $338.21 −1.34% settles Dec 11
- Nov 2, 202615d ago Court Ruling Neutral 2/10 Entry $337.98 Now $338.21 +0.07% settles Dec 2
- Oct 27, 202621d ago Court Ruling Neutral 1/10 Entry $339.30 Now $338.21 −0.32% settles Nov 25
- Oct 26, 202622d ago Court Ruling Neutral 1/10 Entry $335.79 Now $338.21 +0.72% settles Nov 24
- Oct 22, 202626d ago Court Ruling Neutral 1/10 Entry $331.58 Now $338.21 +2.00% settles Nov 20
- Oct 22, 202626d ago Court Ruling Neutral 1/10 Entry $331.58 Now $338.21 +2.00% settles Nov 20
- Oct 21, 202627d ago Court Ruling Neutral 1/10 Entry $336.54 Now $338.21 +0.50% settles Nov 19
- Oct 20, 202627d ago 8-K Neutral 2/10 Entry $335.19 Now $338.21 +0.90% settles Nov 18
- Oct 20, 202628d ago Court Ruling Neutral 1/10 Entry $335.19 Now $338.21 +0.90% settles Nov 18
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers